|Awarded On||August 21, 2019|
|Title||Recombinant Antibody Production Core (RAPC)at Science Park|
|Award Mechanism||Core Facility Support Awards|
|Institution/Organization||The University of Texas M.D. Anderson Cancer Center|
|Principal Investigator/Program Director||Kevin McBride|
|Cancer Sites||All Sites|
*Pending contract negotiation
Antibodies are commonly used reagents in research, diagnostics and therapeutics. They are specialized proteins, evolved by immune cells to specifically recognize foreign particles (antigens) and bind with high affinity. These properties make antibodies valuable tools in biomedical research and clinical applications. Obtaining antibodies to a desired target (for example a protein made by a tumor cell or invading virus) allows investigators to identify, purify and track targets. However, two major issues have negatively impacted biomedical and research use of antibodies. First, the ability and cost to make quality antibodies against desired targets (such as those that detect a chemical modifi...